首页|Data on Cancer Reported by Maksym Druchok and Colleagues (Cancer Immunotherapies Ignited by a Thorough Machine Learning- Based Selection of Neoantigens)
Data on Cancer Reported by Maksym Druchok and Colleagues (Cancer Immunotherapies Ignited by a Thorough Machine Learning- Based Selection of Neoantigens)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Cancer is the subject of a report. According to news originatingfrom Lviv, Ukraine, by NewsRx corresp ondents, research stated, “Identification of neoantigens, derivedfrom somatic D NA alterations, emerges as a promising strategy for cancer immunotherapies. Howe ver,not all somatic mutations result in immunogenicity, hence, efficient tools to predict the immunogenicity ofneoepitopes are needed.”
LvivUkraineEuropeBusinessCancerCyborgsDrugs and TherapiesEmerging TechnologiesHealth and MedicineImmun otherapyMachine LearningOncology
NETL
NSTL
